Aberdare Management Company, LLC 4
4 · Kezar Life Sciences, Inc. · Filed Jun 27, 2018
Insider Transaction Report
Form 4
Aberdare Management Company, LLC
10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2018-06-25−31,481→ 0 total→ Common Stock (31,481 underlying) - Conversion
Common Stock
2018-06-25+105,162→ 105,162 total - Conversion
Common Stock
2018-06-25+31,481→ 136,643 total - Conversion
Series A Convertible Preferred Stock
2018-06-25−105,162→ 0 total→ Common Stock (105,162 underlying)
Footnotes (2)
- [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]The members of Aberdare Management Company, LLC are Paul H. Klingenstein and Kathleen R. Bole.